June 21 (Bloomberg) -- Dr. Reddy’s Laboratories Ltd., India’s biggest drugmaker, is developing eight generic medicines using biotechnology and plans to release one for sale a year, challenging companies such as Roche Holding NV and Amgen Inc.
June 21 (Bloomberg) -- Dr. Reddy’s Laboratories Ltd., India’s biggest drugmaker, is developing eight generic medicines using biotechnology and plans to release one for sale a year, challenging companies such as Roche Holding NV and Amgen Inc.
